Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1987 Jun;23(6):721–725. doi: 10.1111/j.1365-2125.1987.tb03107.x

Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol.

S M Rogers, D J Back, P J Stevenson, S F Grimmer, M L Orme
PMCID: PMC1386167  PMID: 3111513

Abstract

The effect of a single dose of paracetamol (1 g) on plasma concentrations of the oral contraceptive steroids ethinyloestradiol (EE2) and levonorgestrel (LNG) has been studied in six healthy female volunteers. The area under the plasma concentration-time curve (AUC0-24) of EE2 was significantly increased following paracetamol administration by 22% (control 2221 +/- 291; following paracetamol, 2702 +/- 452 pg ml-1 h; mean +/- s.d.; P less than or equal to 0.05). The greatest effect was evident in the time period 0-3 h. There was a significant decrease in the AUC of EE2-sulphate after paracetamol (7736 +/- 3791 pg ml-1 h) compared with control (13161 +/- 4535 pg ml-1 h; P less than or equal to 0.05). Plasma concentrations of LNG were unaltered by concurrent paracetamol administration. We conclude that the administration of a single 1 g dose of paracetamol causes an increase in plasma concentrations of EE2 as a result of a reduction in the sulphation of the steroid. This interaction may be of clinical significance in women on oral contraceptive steroids who regularly take paracetamol.

Full text

PDF
721

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Back D. J., Bates M., Breckenridge A. M., Hall J. M., MacIver M., Orme M. L., Park B. K., Rowe P. H. The pharmacokinetics of levonorgestrel and ethynylestradiol in women - studies with Ovran and Ovranette. Contraception. 1981 Mar;23(3):229–239. doi: 10.1016/0010-7824(81)90045-7. [DOI] [PubMed] [Google Scholar]
  2. Back D. J., Breckenridge A. M., Crawford F. E., MacIver M., Orme M. L., Rowe P. H., Watts M. J. An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay. Contraception. 1979 Sep;20(3):263–273. doi: 10.1016/0010-7824(79)90098-2. [DOI] [PubMed] [Google Scholar]
  3. Back D. J., Breckenridge A. M., MacIver M., Orme M. L., Purba H., Rowe P. H. Interaction of ethinyloestradiol with ascorbic acid in man. Br Med J (Clin Res Ed) 1981 May 9;282(6275):1516–1516. doi: 10.1136/bmj.282.6275.1516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Back D. J., Breckenridge A. M., MacIver M., Orme M., Purba H. S., Rowe P. H., Taylor I. The gut wall metabolism of ethinyloestradiol and its contribution to the pre-systemic metabolism of ethinyloestradiol in humans. Br J Clin Pharmacol. 1982 Mar;13(3):325–330. doi: 10.1111/j.1365-2125.1982.tb01382.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clements J. A., Critchley J. A., Prescott L. F. The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man. Br J Clin Pharmacol. 1984 Oct;18(4):481–485. doi: 10.1111/j.1365-2125.1984.tb02495.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Galinsky R. E., Levy G. Dose- and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion. J Pharmacol Exp Ther. 1981 Oct;219(1):14–20. [PubMed] [Google Scholar]
  7. Hendrix-Treacy S., Wallace S. M., Hindmarsh K. W., Wyant G. M., Danilkewich A. The effect of acetaminophen administration on its disposition and body stores of sulphate. Eur J Clin Pharmacol. 1986;30(3):273–278. doi: 10.1007/BF00541527. [DOI] [PubMed] [Google Scholar]
  8. Houston J. B., Levy G. Drug biotransformation interactions in man VI: acetaminophen and ascorbic acid. J Pharm Sci. 1976 Aug;65(8):1218–1221. doi: 10.1002/jps.2600650822. [DOI] [PubMed] [Google Scholar]
  9. Levy G., Galinsky R. E., Lin J. H. Pharmacokinetic consequences and toxicologic implications of endogenous cosubstrate depletion. Drug Metab Rev. 1982;13(6):1009–1020. doi: 10.3109/03602538208991374. [DOI] [PubMed] [Google Scholar]
  10. Levy G., Matsuzawa T. Pharmacokinetics of salicylamide elimination in man. J Pharmacol Exp Ther. 1967 May;156(2):285–293. [PubMed] [Google Scholar]
  11. Levy G., Yamada H. Drug biotransformation interactions in man. 3. Acetaminophen and salicylamide. J Pharm Sci. 1971 Feb;60(2):215–221. doi: 10.1002/jps.2600600212. [DOI] [PubMed] [Google Scholar]
  12. Morris M. E., Levy G. Serum concentration and renal excretion by normal adults of inorganic sulfate after acetaminophen, ascorbic acid, or sodium sulfate. Clin Pharmacol Ther. 1983 Apr;33(4):529–536. doi: 10.1038/clpt.1983.72. [DOI] [PubMed] [Google Scholar]
  13. Prescott L. F. Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol. 1980 Oct;10 (Suppl 2):291S–298S. doi: 10.1111/j.1365-2125.1980.tb01812.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rogers S. M., Back D. J., Orme M. L. Intestinal metabolism of ethinyloestradiol and paracetamol in vitro: studies using Ussing chambers. Br J Clin Pharmacol. 1987 Jun;23(6):727–734. doi: 10.1111/j.1365-2125.1987.tb03108.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES